MENU
MNPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Monopar Therapeutics (MNPR) Earnings Date & Reports
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology... Show more
A.I. Advisor
published Earnings
MNPR is expected to report earnings to rise 32.10% to -80 cents per share on November 06
Q3'26
Est.
$-0.81
Q4'25
Missed
by $0.53
Q3'25
Missed
by $0.39
Q2'25
Missed
by $0.26
Q1'25
Missed
by $0.29
The last earnings report on March 27 showed earnings per share of -61 cents, missing the estimate of -7 cents. With 59.83K shares outstanding, the current market capitalization sits at 723.04M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company, which engages in building a drug development pipeline of oncology therapeutics in late preclinical and clinical development stages
Industry Biotechnology
Profile
Details
Industry
N/A
Address
1000 Skokie Boulevard
Phone
+1 847 388-0349
Employees
22
Web
https://www.monopartx.com